Trademark: 88446393
Word
INTRATUS
Status Date
Thursday, January 6, 2022
Filing Date
Friday, May 24, 2019
Published for Opposition
Tuesday, March 31, 2020
41 Continuing education services, namely, providing live and on-line continuing professional education seminars in the field of medicine and more specifically those fields of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes as they relate to current treatments; Continuing education services, namely, providing live and on-line continuing professional education seminars in the legal, medical, accounting, and real estate fields; Education services, namely, providing tutorial sessions in the fields of medicine and more specifically those fields of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes as they relate to current treatments; Providing continuing medical education courses
5 Anesthetics for non-surgical use; Balms for medical purposes; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical and medical purposes, namely, for Ophthalmology, Allergy and Immunology, Cardiovascular, and Type II Diabetes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of emollients that facilitate the delivery of pharmaceutical preparations; Emollients for medical purposes; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for ocular and intraocular surgery; Pharmaceutical preparations for the treatment and prevention of dry eye and glaucoma and other ocular disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment of ocular disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for ophthalmic conditions, allergies, immune system diseases, cardiovascular, and type II diabetes; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Topical anesthetics
25 Hats; Hoodies; Jackets; Shirts; Sweatshirts; Wearable garments and clothing, namely, shirts
1 Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Plant extracts for use in the manufacture of creams, lotions and cosmetic products
44 Clinical medical practice consultation services; Medical clinic services; Medical services; Ophthalmology services; Medical treatment of dry eye and or glaucoma and other ocular disorders; Medical diagnosis and treatment of dry eye and or glaucoma and other ocular disorders
10 Drug delivery systems; Medical devices for nonsurgical cosmetic treatments; Medical apparatus for introducing pharmaceutical preparations into the human body
42 Clinical research in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Medical research; Medical and scientific research in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of technology in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Scientific research for medical purposes in the field of Ophthalmology, Allergy and Immunology, Cardiovascular, Type II Diabetes; Biochemical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Pharmaceutical research and development
May 28, 2019
New Application Entered
Feb 16, 2020
Teas Change Of Correspondence Received
Jun 11, 2019
New Application Office Supplied Data Entered
Aug 13, 2019
Assigned To Examiner
Aug 15, 2019
Non-Final Action Written
Aug 15, 2019
Non-Final Action E-Mailed
Aug 15, 2019
Notification Of Non-Final Action E-Mailed
Feb 16, 2020
Teas Response To Office Action Received
Feb 16, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 16, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 21, 2020
Assigned To Lie
Feb 22, 2020
Correspondence Received In Law Office
Feb 22, 2020
Teas/Email Correspondence Entered
Mar 11, 2020
Notification Of Notice Of Publication E-Mailed
Feb 24, 2020
Approved For Pub - Principal Register
Mar 31, 2020
Published For Opposition
Mar 31, 2020
Official Gazette Publication Confirmation E-Mailed
May 26, 2020
Noa E-Mailed - Sou Required From Applicant
Nov 27, 2020
Sou Extension 1 Filed
Dec 28, 2020
Abandonment - No Use Statement Filed
Feb 1, 2021
Use Amendment Filed
Feb 21, 2021
Case Assigned To Intent To Use Paralegal
Dec 28, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 1, 2021
Petition To Revive-Granted
Feb 1, 2021
Teas Petition To Revive Received
Feb 1, 2021
Sou Extension Received With Teas Petition
Feb 1, 2021
Teas Statement Of Use Received
Feb 2, 2021
Notice Of Revival - E-Mailed
Feb 21, 2021
Sou Extension 1 Granted
Feb 21, 2021
Statement Of Use Processing Complete
Feb 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2021
Su - Non-Final Action - Written
Mar 13, 2021
Non-Final Action E-Mailed
Mar 13, 2021
Notification Of Non-Final Action E-Mailed
Sep 12, 2021
Teas Response To Office Action Received
Sep 16, 2021
Assigned To Lie
Oct 12, 2021
Notification Of Final Refusal Emailed
Sep 16, 2021
Correspondence Received In Law Office
Sep 16, 2021
Teas/Email Correspondence Entered
Oct 12, 2021
Final Refusal E-Mailed
Oct 12, 2021
Su - Final Refusal - Written
Nov 26, 2021
Petition To Revive-Granted
Nov 26, 2021
Teas Statement Of Use Received
Nov 26, 2021
Teas Petition To Revive Received
Nov 26, 2021
Sou Extension Received With Teas Petition
Nov 26, 2021
Petition To Revive-Received
Nov 27, 2021
Notice Of Revival - E-Mailed
Jan 6, 2022
Assigned To Petition Staff
Jan 6, 2022
Petition To Revive Dismissed
Jan 6, 2022
Attorney Review/Decision On Amendment Required
Trademark Alertz updated from USPTO on 2030-01-24
